Matthew C. Busch - Net Worth and Insider Trading

Matthew C. Busch Net Worth

The estimated net worth of Matthew C. Busch is at least $1 Million dollars as of 2025-05-09. Matthew C. Busch is the VP, Finance & CAO of Amgen Inc and owns about 4,034 shares of Amgen Inc (AMGN) stock worth over $1 Million. Details can be seen in Matthew C. Busch's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Matthew C. Busch has not made any transactions after 2025-05-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Matthew C. Busch

To

Matthew C. Busch Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Matthew C. Busch owns 1 companies in total, including Amgen Inc (AMGN) .

Click here to see the complete history of Matthew C. Busch’s form 4 insider trades.

Insider Ownership Summary of Matthew C. Busch

Ticker Company Transaction Date Type of Owner
AMGN Amgen Inc 2025-05-02 VP & Finance & CAO

Matthew C. Busch Latest Holdings Summary

Matthew C. Busch currently owns a total of 1 stock. Matthew C. Busch owns 4,034 shares of Amgen Inc (AMGN) as of May 2, 2025, with a value of $1 Million.

Latest Holdings of Matthew C. Busch

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AMGN Amgen Inc 2025-05-02 4,034 272.05 1,097,450

Holding Weightings of Matthew C. Busch


Matthew C. Busch Form 4 Trading Tracker

According to the SEC Form 4 filings, Matthew C. Busch has made a total of 1 transactions in Amgen Inc (AMGN) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Amgen Inc is the sale of 1,000 shares on May 2, 2025, which brought Matthew C. Busch around $279,690.

Insider Trading History of Matthew C. Busch

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Matthew C. Busch Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Matthew C. Busch Ownership Network

Ownership Network List of Matthew C. Busch

No Data

Ownership Network Relation of Matthew C. Busch

Insider Network Chart


Matthew C. Busch Owned Company Details

What does Amgen Inc do?

Who are the key executives at Amgen Inc?

Matthew C. Busch is the VP & Finance & CAO of Amgen Inc. Other key executives at Amgen Inc include EVP & Research and Development David M Reese , EVP & Operations Esteban Santos , and SVP & Human Resources Derek Miller .

Amgen Inc (AMGN) Insider Trades Summary

Over the past 18 months, Matthew C. Busch made 1 insider transaction in Amgen Inc (AMGN) with a net sale of 1,000. Other recent insider transactions involving Amgen Inc (AMGN) include a net sale of 5,802 shares made by Nancy A. Grygiel , a net sale of 33,936 shares made by David M Reese , and a net sale of 25,045 shares made by Jonathan P Graham .

In summary, during the past 3 months, insiders sold 54,442 shares of Amgen Inc (AMGN) in total and bought 0 shares, with a net sale of 54,442 shares. During the past 18 months, 85,289 shares of Amgen Inc (AMGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 85,289 shares.

Amgen Inc (AMGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Amgen Inc Insider Transactions

No Available Data

Matthew C. Busch Mailing Address

Above is the net worth, insider trading, and ownership report for Matthew C. Busch. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Matthew C. Busch's mailing address is: Thousand Oaks Ca 91320.